Elevated C-Reactive Protein Amplifies Association of Lipoprotein(a) With Cardiovascular Risk and Clinical Benefit of Alirocumab

Authors :: Gregory G. Schwartz
Michael Szarek
Andreas Zeiher
Harvey D. White
J. Wouter Jukema
Robert A. Harrington
Shaun G. Goodman
Rafael Diaz
Vera Bittner
Deepak L. Bhatt
Ph. Gabriel Steg
Source :: Journal of the American College of Cardiology. 80(24)
Publication Year :: 2022

Subjects :: C-Reactive Protein
Cardiovascular Diseases
Risk Factors
Heart Disease Risk Factors
Humans
Cardiology and Cardiovascular Medicine
Lipoprotein(a)

Tools